AM-Pharma
Biotechnology ResearchUtrecht, Netherlands11-50 Employees
AM-Pharma BV is a biopharmaceutical company developing recombinant Alkaline Phosphatase for clinical use.
Insights
Recent Partnerships AM-Pharma has recently partnered with KBI Biopharma Inc. to collaborate on a commercial manufacturing agreement for its recombinant human Alkaline Phosphatase program. This partnership presents an opportunity for sales development representatives to explore potential collaborations and sales channels within the biopharmaceutical industry.
Strategic Acquisitions Pfizer, Inc. acquired AM-Pharma in 2018, showcasing a strategic interest in the company's approach and technologies. This acquisition history indicates that AM-Pharma's offerings align with major players in the pharmaceutical industry, presenting potential sales opportunities for business development professionals to leverage existing relationships and explore new prospects.
Key Executive Appointments AM-Pharma has appointed key executives, such as Chief Financial Officer Lars R. Boesgaard and Chairman of Supervisory Board Mark Altmeyer. Engaging with these key decision-makers presents a strategic sales opportunity for developing relationships, understanding the company's vision, and positioning products or services that cater to AM-Pharma's strategic direction.
CEO Leadership Change With the recent appointment of Juliane Bernholz as Chief Executive Officer, AM-Pharma signals a shift in leadership focus. Engaging with a new CEO presents an opportunity for sales development representatives to introduce innovative solutions that align with the CEO's vision, contributing to potential sales growth and partnerships.
Market Expansion AM-Pharma's focus on developing therapeutics for severe medical conditions opens up opportunities for sales in emerging markets and healthcare segments. Sales development representatives can explore market expansion strategies, partnerships, and collaborations to position products or services that cater to the company's commitment to addressing critical medical needs.
AM-Pharma Tech Stack
AM-Pharma uses 8 technology products and services including jQuery CDN, Shopify, Google Font API, and more. Explore AM-Pharma's tech stack below.
- jQuery CDNContent Delivery Network
- ShopifyE-commerce
- Google Font APIFont Scripts
- RSSMiscellaneous
- PHPProgramming Languages
- MediaElement.jsVideo Players
- YouTubeVideo Players
- NginxWeb Servers
Media & News
AM-Pharma's Email Address Formats
AM-Pharma uses at least 1 format(s):
| AM-Pharma Email Formats | Percentage |
| F.Last@am-pharma.com | 82% |
| First-Last@am-pharma.com | 8% |
| FirMLast@am-pharma.com | 5% |
| Last@am-pharma.com | 5% |
Frequently Asked Questions
Where is AM-Pharma's headquarters located?
AM-Pharma's main headquarters is located at Stadsplateau 6 Utrecht, 3521 AZ NL. The company has employees across 5 continents, including EuropeAfricaNorth America. What is AM-Pharma's phone number?
You can contact AM-Pharma's main corporate office by phone at +31-30-228-****
What is AM-Pharma's official website and social media links?
AM-Pharma's official website is am-pharma.com and has social profiles on LinkedIn.How much revenue does AM-Pharma generate?
As of February 2024, AM-Pharma's annual revenue reached $3.8M. What is AM-Pharma's SIC code NAICS code?
AM-Pharma's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does AM-Pharma have currently?
As of February 2024, AM-Pharma has approximately 21 employees across 5 continents, including EuropeAfricaNorth America. Key team members include Chief Executive Officer: J. B.Vice President Of Clinical Operations: K. B.Vice President Global Commercial Strategy & Business Development: M. N. M.. Explore AM-Pharma's employee directory with LeadIQ.What industry does AM-Pharma belong to?
AM-Pharma operates in the Biotechnology Research industry. What technology does AM-Pharma use?
AM-Pharma's tech stack includes jQuery CDNShopifyGoogle Font APIRSSPHPMediaElement.jsYouTubeNginx. What is AM-Pharma's email format?
AM-Pharma's email format typically follows the pattern of . Find more AM-Pharma email formats with LeadIQ. When was AM-Pharma founded?
AM-Pharma was founded in 2002.
Company Overview
- Headquarters
- Stadsplateau 6 Utrecht, 3521 AZ NL
- Phone number
- +31-30-228-****
- Website
- am-pharma.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2002
- Employees
- 11-50
Media & News
Funding & Financials
- $10M
AM-Pharma's revenue is in the range of $10M
Funding & Financials
- $10M
AM-Pharma's revenue is in the range of $10M
Company Leadership
J. B.Chief Executive Officer
K. B.Vice President Of Clinical Operations- M. N. M.Vice President Global Commercial Strategy & Business Development
- P. V.Vice President Finance
S. C.VP Dev & Manufacture
Employee Directory
- S. C.VP Dev & Manufacture
- W. M.Vice President Ra And Qm
- M. W.Sr. Director Clinical Data Management
- L. H.Sr Director Project Management Office
- S. V. D. B.Sr Director Finance
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
